Armata Pharmaceuticals (ARMP) EBT Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.15% |
| Dec 31, 2025 | -23.28% |
| Sep 30, 2025 | -16.01% |
| Jun 30, 2025 | -17.73% |
| Mar 31, 2025 | -18.35% |
| Dec 31, 2024 | -24.68% |
| Sep 30, 2024 | -12.76% |
| Jun 30, 2024 | -27.97% |
| Mar 31, 2024 | -26.53% |
| Dec 31, 2023 | -58.35% |
| Sep 30, 2023 | -32.85% |
| Jun 30, 2023 | -24.79% |
| Mar 31, 2023 | -29.97% |
| Dec 31, 2022 | -32.76% |
| Sep 30, 2022 | -61.71% |
| Jun 30, 2022 | -3.49% |
| Mar 31, 2022 | -21.16% |
| Dec 31, 2021 | -32.14% |
| Sep 30, 2021 | -20.94% |
| Jun 30, 2021 | -9.97% |
| Mar 31, 2021 | -3.99% |
| Dec 31, 2020 | -17.39% |
| Sep 30, 2020 | -20.20% |
| Jun 30, 2020 | -12.69% |
| Mar 31, 2020 | -13.48% |
| Dec 31, 2019 | -12.04% |
| Sep 30, 2019 | -5.86% |
| Jun 30, 2019 | -2.30% |
| Mar 31, 2019 | 20.03% |
| Dec 31, 2018 | 15.70% |
| Sep 30, 2018 | -3.35% |
| Jun 30, 2018 | 12.72% |
| Mar 31, 2018 | -16.41% |